×
About 8,408 results

ALLMedicine™ Eclampsia Center

Research & Reviews  2,997 results

A blood test to predict pre‑eclampsia.
https://doi.org/10.1038/d41591-022-00027-x
Nature Medicine; O'Leary K

Jan 22nd, 2022 - A blood test to predict pre‑eclampsia.|2022|O'Leary K,|

Posterior reversible encephalopathy syndrome in the puerperium: a case report.
https://doi.org/10.1136/bcr-2021-246570
BMJ Case Reports; Dunphy L, Kothari T et. al.

Jan 21st, 2022 - Headache is a common presentation to the physician. Although most causes of a headache in pregnancy are benign, the pregnant woman is at risk of a life-threatening secondary headache such as eclampsia, venous sinus thrombosis or posterior reversib...

Posterior reversible encephalopathy syndrome (PRES): diagnosis and management.
https://doi.org/10.1136/practneurol-2021-003194
Practical Neurology; Triplett JD, Kutlubaev MA et. al.

Jan 21st, 2022 - Posterior reversible encephalopathy syndrome (PRES) may present with diverse clinical symptoms including visual disturbance, headache, seizures and impaired consciousness. MRI shows oedema, usually involving the posterior subcortical regions. Trig...

Racial and ethnic disparities in maternal and neonatal outcomes among women with chroni...
https://doi.org/10.1055/a-1745-2902
American Journal of Perinatology; Stearns K, Tsaih SW et. al.

Jan 20th, 2022 - To compare maternal and neonatal outcomes in women with chronic hypertension by maternal race and ethnicity. A retrospective cohort study of women with chronic hypertension from the Consortium on Safe Labor (2002-2008). Maternal self-reported race...

see more →

Guidelines  8 results

ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-ecl...
https://doi.org/10.1002/uog.20105
Ultrasound in Obstetrics & Gynecology : the Official Jour... Sotiriadis A, Hernandez-Andrade E et. al.

Oct 16th, 2018 - ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia.|2018|Sotiriadis A,Hernandez-Andrade E,da Silva Costa F,Ghi T,Glanc P,|diagnosis,diagnostic imaging,

Assessment of arterial function in pregnancy: recommendations of the International Work...
https://doi.org/10.1002/uog.17565
Ultrasound in Obstetrics & Gynecology : the Official Jour... Foo FL, McEniery CM et. al.

Jul 2nd, 2017 - There is strong evidence supporting the role of maternal arterial dysfunction in pregnancy-specific disorders such as pre-eclampsia and intrauterine growth restriction. As more work is focused towards this field, it is important that methods and i...

Screening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.
https://doi.org/10.1001/jama.2017.3439
JAMA , Bibbins-Domingo K et. al.

Apr 27th, 2017 - Preeclampsia affects approximately 4% of pregnancies in the United States. It is the second leading cause of maternal mortality worldwide and may lead to serious maternal complications, including stroke, eclampsia, and organ failure. Adverse perin...

Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertensio...
https://doi.org/10.1097/AOG.0000000000002010
Obstetrics and Gynecology;

Mar 24th, 2017 - Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; s...

Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During...
https://doi.org/10.1097/AOG.0000000000002019
Obstetrics and Gynecology;

Mar 24th, 2017 - Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; s...

see more →

Drugs  58 results see all →

Clinicaltrials.gov  100 results

Gestational Diabetes and Pharmacotherapy (GAP)
https://clinicaltrials.gov/ct2/show/NCT03527537

Jan 11th, 2022 - Gestational diabetes mellitus (GDM) affects 5-8% of pregnant women, many of whom will require treatment beyond diet and exercise. Despite this high prevalence, there is no consensus regarding the glycemic threshold for conversion from diet to medi...

Innovations in Placental Metabolism and Association With Antioxidants and Nutrients in Diabetes and Gestational Obesity
https://clinicaltrials.gov/ct2/show/NCT05174728

Jan 3rd, 2022 - This research project aims to investigate, in an innovative way, the molecular pathophysiology of gestational complications induced by maternal obesity and gestational diabetes mellitus (GDM). These complications have an immediate impact on obstet...

The Clinical and Prognostic Features of PRES
https://clinicaltrials.gov/ct2/show/NCT05143710

Dec 20th, 2021 - The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of cl...

Nifedipine Dosing Daily vs Twice a Day for Pre-eclampsia With Severe Features (NOPPI)
https://clinicaltrials.gov/ct2/show/NCT05096728

Dec 17th, 2021 - This is a randomized controlled unblinded trial at The Ohio State University comparing Nifedipine XL 60mg daily to 30mg twice daily in patients admitted for expectant management for pre-eclampsia with severe features. Potential study participants ...

Measuring sVAP-1 as a Predictor of Pregnancy Problems
https://clinicaltrials.gov/ct2/show/NCT04891315

Nov 30th, 2021 - Pre-eclampsia is a common pregnancy disorder defined as high blood pressure and protein in the urine after 20 weeks of pregnancy. It affects the function of the placenta and can cause severe complications, e.g, stroke, multiple organ damage and se...

see more →

News  199 results

New Blood Test Could Identify Pregnant Women who are at Risk of Pre-eclampsia
https://www.medscape.com/viewarticle/966129

Jan 6th, 2022 - Pregnant women who are at risk of pre-eclampsia can now be identified early before symptoms develop, finds new research from Kings College London and Guy's and St Thomas' NHS Foundation Trust, published today in Nature . The study, supported by th...

Pre-eclampsia/Eclampsia Tied to Increased Risk of Heart Failure for at Least 10 Years
https://www.medscape.com/viewarticle/964164

Dec 6th, 2021 - NEW YORK (Reuters Health) - Women with pre-eclampsia/eclampsia were at increased risk for future heart failure (HF) for up to a decade in a large cohort study. "While preeclampsia has previously been recognized as a risk factor for future cardiova...

Identify patient and hospital factors to reduce maternal mortality
https://www.mdedge.com/obgyn/article/247891/diversity-medicine/identify-patient-and-hospital-factors-reduce-maternal
Heidi Splete

Oct 26th, 2021 - Maternal mortality is a public health crisis for all women, said Elizabeth A. Howell, MD, of the University of Pennsylvania, Philadelphia, in a presentation at the virtual Advancing NIH Research on the Health of Women conference sponsored by the N.

COVID-19 Disease May Actually Cause Preeclampsia, Suggests Study
https://www.medscape.com/viewarticle/958156

Sep 3rd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New evidence strongly suggests that COVID-19 disease causes an increased risk of preeclampsia and preterm birth in those who have an infection whi...

NHS England to Offer Pre-eclampsia Blood Test
https://www.medscape.com/viewarticle/957269

Aug 26th, 2021 - NHS England has routinely rolled out a new blood test known as placental growth factor (PLGF) testing to rule out pre-eclampsia in pregnant women. The test which has already benefitted tens of thousands of women is expected to be available across ...

see more →

Patient Education  1 results see all →